Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Therapeutic Drug Monitoring
|
January 1, 1989
A high-performance liquid chromatographic method for the determination of encainide and its major metabolites in urine and serum using solid-phase extraction
D J Kazierad, T J Hoon, M B Bottorff
The Annals of Pharmacotherapy
|
February 11, 2000
Homocysteine as a risk factor for atherosclerosis
M E Temple, A B Luzier, D J Kazierad
Pharmacotherapy
|
January 1, 1990
Dilevalol: an overview of its clinical pharmacology and therapeutic use in hypertension
R L Lalonde, D M Tenero, D J Kazierad
Pharmacotherapy
|
April 23, 1999
A review of eprosartan pharmacokinetic and pharmacodynamic drug interaction studies
R A Blum, D J Kazierad, D M Tenero
Pharmacotherapy
|
March 1, 1993
The effect of isradipine on theophylline pharmacokinetics in healthy volunteers
M M Perreault, D J Kazierad, J H Wilton, et al.
Journal of Clinical Pharmacology
|
August 14, 1998
The effects of gender on adrenergic receptor responsiveness
A B Luzier, J J Nawarskas, J Añonuevo, et al.
Journal of Clinical Pharmacology
|
February 1, 1995
The effect of verapamil on the nephrotoxic potential of gentamicin as measured by urinary enzyme excretion in healthy volunteers
D J Kazierad, G J Wojcik, D E Nix, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1989
The effect of diltiazem on the disposition of encainide and its active metabolites
D J Kazierad, R L Lalonde, T J Hoon, et al.
Clinical Pharmacology and Therapeutics
|
December 29, 1999
Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers
A B Luzier, A Killian, J H Wilton, et al.
Journal of Clinical Pharmacology
|
August 14, 1998
Eprosartan does not affect the pharmacodynamics of warfarin
D J Kazierad, D E Martin, B Ilson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Therapeutic Drug Monitoring
|
January 1, 1989
A high-performance liquid chromatographic method for the determination of encainide and its major metabolites in urine and serum using solid-phase extraction
D J Kazierad, T J Hoon, M B Bottorff
The Annals of Pharmacotherapy
|
February 11, 2000
Homocysteine as a risk factor for atherosclerosis
M E Temple, A B Luzier, D J Kazierad
Pharmacotherapy
|
January 1, 1990
Dilevalol: an overview of its clinical pharmacology and therapeutic use in hypertension
R L Lalonde, D M Tenero, D J Kazierad
Pharmacotherapy
|
April 23, 1999
A review of eprosartan pharmacokinetic and pharmacodynamic drug interaction studies
R A Blum, D J Kazierad, D M Tenero
Pharmacotherapy
|
March 1, 1993
The effect of isradipine on theophylline pharmacokinetics in healthy volunteers
M M Perreault, D J Kazierad, J H Wilton, et al.
Journal of Clinical Pharmacology
|
August 14, 1998
The effects of gender on adrenergic receptor responsiveness
A B Luzier, J J Nawarskas, J Añonuevo, et al.
Journal of Clinical Pharmacology
|
February 1, 1995
The effect of verapamil on the nephrotoxic potential of gentamicin as measured by urinary enzyme excretion in healthy volunteers
D J Kazierad, G J Wojcik, D E Nix, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1989
The effect of diltiazem on the disposition of encainide and its active metabolites
D J Kazierad, R L Lalonde, T J Hoon, et al.
Clinical Pharmacology and Therapeutics
|
December 29, 1999
Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers
A B Luzier, A Killian, J H Wilton, et al.
Journal of Clinical Pharmacology
|
August 14, 1998
Eprosartan does not affect the pharmacodynamics of warfarin
D J Kazierad, D E Martin, B Ilson, et al.
Page
of 2